{
    "clinical_study": {
        "@rank": "25128", 
        "acronym": "Septilin", 
        "arm_group": [
            {
                "arm_group_label": "Test Group", 
                "arm_group_type": "Active Comparator", 
                "description": "Patients in Test Group were given Herbal Immunomodulators (SeptilinTM) 2 tablets twice daily for 3 weeks then medications were stopped and changes in all parameters were again checked after 6 weeks."
            }, 
            {
                "arm_group_label": "Control Group", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Patients in Control Group were given placebo drug 2 tablets twice daily for 3 weeks then medications were stopped and changes in all parameters were again checked after 6 weeks."
            }
        ], 
        "brief_summary": {
            "textblock": "Addition of systemic herbal immunomodulators with scaling & root planing (SRP) may enhance\n      the therapeutic result of Chronic Periodontitis owing to host modulation & anti-inflammatory\n      properties. If proven, herbal immunomodulators can be used as an adjunct to SRP."
        }, 
        "brief_title": "Role of Herbal Immunomodulators in the Treatment of Chronic Periodontitis", 
        "completion_date": {
            "#text": "October 2013", 
            "@type": "Actual"
        }, 
        "condition": "Chronic Periodontitis", 
        "condition_browse": {
            "mesh_term": [
                "Periodontitis", 
                "Chronic Periodontitis"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. Patients within age group of 30 to 55 years.\n\n          2. Systemically healthy individuals.\n\n          3. Patients with chronic generalized periodontitis (moderate and severe) according to\n             Center of Disease Control (CDC) working group, 2007 criteria\n\n        Exclusion Criteria:\n\n          1. Patients with systemic illnesses (i.e., diabetes mellitus, cancer, human\n             immunodeficiency syndrome, bone metabolic diseases, or disorders that compromise\n             wound healing, radiation, or immunosuppressive therapy),\n\n          2. Smoking,\n\n          3. Chronic alcoholics,\n\n          4. Pregnancy or lactation,\n\n          5. Use of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), steroids or antibiotics /\n             antimicrobials within January 2012 to Jun 2013,\n\n          6. Confirmed or suspected intolerance to herbal medicines,\n\n          7. Periodontal therapy done within the january 2012 to Jun 2013."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "55 Years", 
            "minimum_age": "30 Years"
        }, 
        "enrollment": {
            "#text": "60", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "November 19, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01997814", 
            "org_study_id": "TKDC12"
        }, 
        "intervention": [
            {
                "arm_group_label": "Test Group", 
                "description": "Patients in Test Group were treated with scaling and root planing (SRP) along with Herbal Immunomodulators (Septilin) therapy, 2 tablets twice daily for 3 weeks.", 
                "intervention_name": "herbal immunomodulator", 
                "intervention_type": "Drug", 
                "other_name": "Septilin (brand name)"
            }, 
            {
                "arm_group_label": "Control Group", 
                "description": "Patients in Control Group were treated with scaling and root planing (SRP) along with Placebo therapy, 2 tablets twice daily for 3 weeks.", 
                "intervention_name": "Placebo", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Adjuvants, Immunologic", 
                "Immunologic Factors"
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "Herbal medicine,", 
            "Host modulation therapy,", 
            "Periodontitis,", 
            "Meta-analysis,", 
            "Scaling and root planing."
        ], 
        "lastchanged_date": "November 27, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Kolhapur", 
                    "country": "India", 
                    "state": "Maharashtra", 
                    "zip": "416137"
                }, 
                "name": "Tatyasaheb Kore Dental College and Research Centre, New Pargaon"
            }
        }, 
        "location_countries": {
            "country": "India"
        }, 
        "number_of_arms": "2", 
        "official_title": "EFFECT OF SRP WITH ADJUNCTIVE THERAPY OF HERBAL IMMUNOMODULATORS ON THE SERUM C REACTIVE PROTEIN (CRP) LEVELS & CLINICAL PARAMETERS IN CHRONIC PERIODONTITIS PATIENTS - A RANDOMISED, DOUBLE BLIND, PLACEBO CONTROLLED, CLINICAL TRIAL.", 
        "overall_official": {
            "affiliation": "Post Graduate Student", 
            "last_name": "Girish D Deore, BDS", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "India: Indian Council of Medical Research"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "July 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": [
            {
                "description": "changes from baseline in biochemical parameter, serum CRP levels were assessed at 3 weeks after starting therapy with herbal immunomodulators, then therapy was stopped and same changes were again assessed at 6 weeks from baseline. Serum CRP level was measured in milligram/liter (mg/l)", 
                "measure": "Change from baseline in serum CRP levels at 3 weeks and 6 weeks", 
                "safety_issue": "No", 
                "time_frame": "baseline, 3 weeks, 6 weeks"
            }, 
            {
                "description": "changes from baseline in standard clinical parameter, PD were assessed at 3 weeks after starting therapy with herbal immunomodulators, then therapy was stopped and same changes were again assessed at 6 weeks from baseline. PD was measured in millimeters.", 
                "measure": "changes from baseline in Pocket Depth (PD) at 3 weeks and 6 weeks.", 
                "safety_issue": "No", 
                "time_frame": "baseline, 3 weeks and 6 weeks"
            }, 
            {
                "description": "changes from baseline in standard clinical parameter, CAL were assessed at 3 weeks after starting therapy with herbal immunomodulators, then therapy was stopped and same changes were again assessed at 6 weeks from baseline. PD was measured in millimeters.", 
                "measure": "changes from baseline in Clinical Attachment Level (CAL) at 3 weeks and 6 weeks.", 
                "safety_issue": "No", 
                "time_frame": "baseline, 3 weeks and 6 weeks"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01997814"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Tatyasaheb Kore Dental College", 
            "investigator_full_name": "GIRISH DEORE", 
            "investigator_title": "Principal Investigator", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "changes from baseline in standard clinical parameter, GI were assessed at 3 weeks after starting therapy with herbal immunomodulators, then therapy was stopped and same changes were again assessed at 6 weeks from baseline. GI has a scoring criteria specified by Silness & Loe, 1963.", 
                "measure": "Changes from baseline in Gingival Index (GI) at 3 weeks and 6 weeks", 
                "safety_issue": "No", 
                "time_frame": "baseline, 3 weeks and 6 weeks"
            }, 
            {
                "description": "changes from baseline in standard clinical parameter, PI were assessed at 3 weeks after starting therapy with herbal immunomodulators, then therapy was stopped and same changes were again assessed at 6 weeks from baseline. PI has a scoring criteria specified by  Loe & Silness, 1964.", 
                "measure": "change from baseline in Plaque Index (PI) at 3 weeks and 6 weeks", 
                "safety_issue": "No", 
                "time_frame": "baseline, 3 weeks and 6 weeks"
            }, 
            {
                "description": "changes from baseline in standard clinical parameter, OHIS were assessed at 3 weeks after starting therapy with herbal immunomodulators, then therapy was stopped and same changes were again assessed at 6 weeks from baseline. OHIS has a scoring criteria specified by Greene and Vermilion, 1964.", 
                "measure": "Changes from baseline in Oral Hygiene Index Simplified (OHIS) at 3 weeks and 6 weeks.", 
                "safety_issue": "No", 
                "time_frame": "baseline, 3 weeks and 6 weeks"
            }, 
            {
                "description": "changes from baseline in standard clinical parameter, SBI were assessed at 3 weeks after starting therapy with herbal immunomodulators, then therapy was stopped and same changes were again assessed at 6 weeks from baseline. SBI has a scoring criteria specified by Muhleman's (1971).", 
                "measure": "Changes from baseline in Sulcus Bleeding Index (SBI) at 3 weeks and 6 weeks", 
                "safety_issue": "No", 
                "time_frame": "baseline, 3 weeks and 6 weeks"
            }
        ], 
        "source": "Tatyasaheb Kore Dental College", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Tatyasaheb Kore Dental College", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "March 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "November 2013"
    }
}